Francois Rochon
Giverny Capital
Francois Rochon Healthcare Services Group Inc stake
total: 126
Giverny Capital HCSG trades
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 3
- Held since:
- 2018 Q3
- Held for:
- 13 quarters
- Latest activity:
- 2021 Q4
According to 2026 Q2 report, Francois Rochon doesn't hold any Healthcare Services Group Inc (HCSG) shares. To date, the estimated cost basis is nearly $31.37 for "buy" trades and estimated average "sell" price is $24.9. Giverny Capital first purchased HCSG in 2018 Q3, initially acquiring 9,266 shares. Since the initial investment in Healthcare Services Group Inc (HCSG), Giverny Capital has made 12 more transactions.
When did Francois Rochon sell Healthcare Services Group Inc (HCSG)?
Francois Rochon sold off the entire Healthcare Services Group Inc (HCSG) position in 2021 Q4.
When did Francois Rochon buy Healthcare Services Group Inc (HCSG)?
Francois Rochon first invested in Healthcare Services Group Inc (HCSG) in 2018 Q3 at the reported quarter-end price of $40.58 per share.
What's the cost basis of Giverny Capital's HCSG stake?
The estimated cost basis for Healthcare Services Group Inc (HCSG) stake is around $31.37 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $31.37
- Weighted AVG sell price:
- $24.90
Francois Rochon's historical trades in Healthcare Services Group Inc
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$24.99
|
|
-100% (-370,166)
|
-0.55%
|
|
2021 Q3
|
0.55%
|
370,166
|
$24.99
|
$9,250,000
|
-0.05% (-179)
|
-0%
|
|
2021 Q2
|
0.71%
|
370,345
|
$31.57
|
$11,692,000
|
+1.66% (+6,033)
|
+0.01%
|
|
2021 Q1
|
0.68%
|
364,312
|
$28.03
|
$10,212,000
|
+0.68% (+2,463)
|
+0%
|
|
2020 Q4
|
0.78%
|
$28.10
|
+1.45% (+5,156)
|
|||
|
2020 Q3
|
0.70%
|
$21.53
|
-0.55% (-1,955)
|
|||
|
2020 Q2
|
0.87%
|
$24.46
|
+21.73% (+64,022)
|
|||
|
2020 Q1
|
0.90%
|
$23.91
|
-7.85% (-25,084)
|
|||
|
2019 Q4
|
0.70%
|
$24.32
|
+1.20% (+3,802)
|
|||
|
2019 Q3
|
0.76%
|
$24.29
|
+0.71% (+2,230)
|
|||
|
2019 Q2
|
0.96%
|
$30.32
|
+9.17% (+26,344)
|
|||
|
2019 Q1
|
1.09%
|
$32.99
|
+3,000.95% (+278,068)
|
|||
|
2018 Q3
|
0.04%
|
$40.58
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.